Browse Items (1 total)

Tags: 11, 2-4, 2005, 22, 26, 5-11, Adolescent Anticonvulsants/administration & dosage/adverse effects Child Child, and 12-17-year-old age groups, and 12-17-year-olds, and 33/1000 children chronically prescribed antiepileptic therapy in the 0-1, and six for the 0-1, Backlog, British Journal of Clinical Pharmacology, ciprofloxacin, Computerized Polypharmacy Prescriptions, Drug/statistics & numerical data Primary Health Care/statistics & numerical data Research Support, Ekins-Daukes S, erythromycin, Helms P, Journal Article, McLay JS, Milne RM, Newborn Medical Records Systems, Non-U.S. Gov't Scotland%X AIMS: To investigate the extent of acute coprescribing in primary care to children on chronic antiepileptic therapy, Novak PH, PedPal Lit, Preschool Drug Administration ScheduleDrug Interactions Epilepsy/drug therapy Humans Infant Infant, respectively. Of these acute coprescriptions 72 (1.5%) prescribed to 22 (3.0%) children were identified as a potential source of clinically serious interactions. The age-adjusted prevalence rates for potentially serious coprescribing were 86, respectively. The drugs most commonly coprescribed which could give rise to such interactions were antacids, Simpson CR, six, theophylline and (TRUNCATED), with carbamazepine